Introduction
============

Psychosis is defined as the presence of hallucinations and delusions and is present in a number of psychiatric disorders including schizophrenia, delusional disorders, schizoaffective disorders, and drug-induced psychosis. These symptoms can result in impaired functioning in work and school, and can affect parenting, self-care, independent living, interpersonal relationships, and leisure time ([@B25]). Psychotic disorders are complex illnesses that can have a profound long-term health, psychological and social impact on the individual. Research in the field indicates that complex, interrelated factors can determine the etiology and course of the illness. There is also strong evidence pointing to the relationship between the experiences of trauma and/or adversity and the development of psychosis, including a correlation between trauma and/or adversity in childhood and the development of psychosis ([@B23]).

Estimates of the rates of childhood trauma and/or adversity (CTA) worldwide indicate that every year millions of children experience trauma including physical, sexual, emotional abuse, and severe neglect ([@B17]). The terminology associated with trauma, adversity, and early life stress is often used interchangeably across numerous social and health contexts. In discussing the different interpretations of trauma and adversity, [@B7] provide a definitive definition of trauma and adversity in childhood that encompasses child abuse and neglect. This definition includes the experience of verbal assaults on a child's sense of worth, bodily assaults that pose risk of injury, sexual contact, failure to provide basic psychological/emotional needs, and a failure to provide basic needs ([@B5]; [@B8]). CTA is associated with a range of poor health and psychological outcomes, ([@B31]) and is associated with the development of psychotic disorders in adulthood ([@B15]; [@B21]). In particular, the experience(s) of CTA can lead to high levels of anxiety and is associated with hallucinations, psychological withdrawal, depression, and hopelessness ([@B20]). The health and psychosocial outcomes of CTA can vary according to gender, with women being more likely to experience sexual abuse whilst men tend to be subjected to physical abuse and/or bullying ([@B28]). Additionally, in particular cohorts, such as adult women in drug treatment services, as many as 62--81% report CTA ([@B34]; [@B12]; [@B18]).

While research has been conducted into the influence of CTA, particularly child sexual abuse on health, psychological, and social functioning in female populations, CTA in male cohorts has received less attention, primarily due to its seemingly lower prevalence rates and less overt symptomatic presentation(s). There is widespread evidence that psychosis is correlated with poor physical health, lower levels of educational attainment, and poorer socioeconomic outcomes ([@B19]). People with psychosis can also exhibit higher rates of obesity ([@B33]), illness comorbidity ([@B30]), and substance abuse than in the general population ([@B1]). For those with a history of CTA and who have developed a psychotic disorder, the combination of this serious mental illness along with the challenges of living with the psychological effects of CTA can make health, economic and social functioning extremely difficult ([@B31]).

Despite an extensive collection of research into the effects of psychosis on many of the domains of life there has been little exploration of the physical impact of CTA on people living with psychosis. The present study took place in the northern region of Adelaide, South Australia. This is a disadvantaged region with a high proportion of people in receipt of government benefits, high unemployment rates, lower levels of education, and high rates of mental health ([@B2]). Within this adverse socioeconomic environment, our aim was to determine the prevalence of CTA in people who have psychotic disorders, and to investigate the associations between CTA and a range of psychiatric, social, and health measures. Given that gender differences in both the nature and adult consequences of CTA were likely, we undertook separate analyses for men and for women.

It was expected that co-existing CTA and psychosis would be associated with a poorer outcome than psychosis alone. Additionally, the role of gender in affecting psychosocial and health outcomes was also explored. We expected participants who experienced CTA to have left school earlier, be more likely to be unemployed, and to have poorer economic functioning. We also expected people subject to CTA to be more likely to abuse drugs and alcohol, self-harm and/or attempt suicide. Given their exposure to abuse and/or violence during childhood, we also considered it likely that they would experience stigma, bullying, and/or violence as adults. We also expected that their physical health (both objective and subjective) would be worse. These assumptions are based on evidence in the CTA literature indicating the correlation between CTA and lower socio-economic status, and poor health compared to non-CTA populations.

Materials and Methods {#s1}
=====================

Participants for the study were randomly selected from people who have been in contact with a mental health service or a non-government organization funded to provide mental health services. The SHIP projected utilized a psychosis screener to identify potential participants. Potential participants were screened for psychosis between April 1st, 2009 and March 31st, 2010. The psychosis screener identified potential SHIP participants who were positive for psychosis on the basis of their contact(s) with mental health services or who recorded ICD-10 diagnosis of psychosis. The psychosis screener identified 1825 adults aged 18--64 years who were residents in the South Australian postcode catchment area. Potential participants needed to have been in contact with public mental health services in the 12 months prior to the survey to be eligible to participate in the SHIP study. The exclusion criteria included severe cognitive impairment, the inability to comprehend English sufficiently to complete the interview without the use of an interpreter. Attempts were made to recruit all of these potential participants. Eight hundred and twenty three were unable to be contacted due to change of personal circumstance (e.g., moved away from the catchment area, changed their phone number, were non-responders to phone/mail contact or did not attend the SHIP interview), 16 were known to have died, 33 did not meet inclusion criteria due to inability to sufficiently communicate in English, 42 did not have capacity to give informed consent, and 507 refused. Potential participants were identified during the SHIP census period and in total 402 participants were interviewed. Comparison of screening data for interviewed participants and those selected for interview but not participating for any reason indicated no systematic selection biases. Both groups were alike in terms of sex (60% of those interviewed were male compared to 62% of those selected but not interviewed) and age group (44% of those interviewed were aged 18--34 years at the time of screening compared with 43% of those not interviewed). The psychosis screening profiles for both groups were similar indicating no marked differences in terms of lifetime symptom profiles based on the screener items.

The SHIP interview schedule consisted of 32 modules and asked participants about psychopathology, substance use, physical health, functioning, disability and quality of life, education, employment, accommodation, and childhood adversity. The social, health, and economic profile information of participants consisted of, but were not limited to: demographic status, socioeconomic and psychosocial status, health and physical functioning, diagnosis, and symptomology. Diagnoses were made using the Diagnostic Interview for Psychosis (DIP; [@B9]). The DIP contains selected interview questions and probes from the WHO Schedules for Clinical Assessment in Neuropsychiatry ([@B35]) mapped onto the 90 diagnostic items of the operational criteria checklist for psychotic and affective illness ([@B22]). The DIP measured both lifetime and current illness symptoms for psychosis. A computer algorithm provided the diagnostic classification in accordance with ICD-10, DSM-IV, and other criteria on the basis of the DIP scores. This reduced the subjective bias in the interpretation of symptoms and signs ([@B29]). No specific analysis was conducted regarding the non-responders to the SHIP research project. Further information regarding the method of the SHIP research project is detailed in [@B24].

Questions regarding the occurrence and nature of CTA were included in the interview. In Australia, all states follow a national framework of guidelines for defining the four types of child abuse (a) sexual abuse, (b) physical abuse, (c) emotional abuse, and (d) neglect. The classification of reported CTA was undertaken in collaboration with staff from the Western Australian Department of Child Protection to ensure conformity to national guidelines. This paper includes only those cases where the CTA is consistent with the standard Australian definitions, took place when the participant was aged 18 years or younger and occurred prior to the onset of psychotic illness.

Ethics Statement
----------------

Ethics approval for this research was obtained from the Human Research Ethics Committee of the Queen Elizabeth Hospital (Protocol number: 2009179).

Assessments
-----------

The Second Australian Survey of Psychosis 2010 interview schedule was comprised of 32 modules, including the Alcohol Use Disorders Identification Test ([@B4]), the World Health Organization Schedules for Clinical Assessment in Neuropsychiatry ([@B16]; [@B36]). The details for all other measures are described in [@B24].

Childhood Trauma and/or Adversity
---------------------------------

Questions about the occurrence and nature of CTA were included in the SHIP interview. CTA was coded on the basis of responses to the question: "Were there any other very distressing or traumatic events in your childhood (not including parental separation or divorce, or loss of a close relative)?"

Statistical Analyses
--------------------

Statistical analyses were performed using Stata, version 12 ([@B32]). A two-step model building procedure was used to determine variables associated with CTA. In the first step, we used univariate analyses (chi-squares and *t*-tests) to examine relationships between CTA and independent variables. In the second step, we used multivariate logistic regressions, including only variables that were significantly associated with CTA status at alpha ≤0.05 in the first step. As the incidence of CTA was much higher in females, the analyses were also stratified by gender to explore gender specific associations. In the final stratified model, only the significant variables were retained, adjusting for possible confounders of health status such as lifetime histories of smoking, heavy alcohol usage and cannabis use.

Given the difference between genders in the numbers reporting CTA, a *post hoc* power analysis with the program G^∗^Power, Version 3.1.9.2 ([@B11]) was conducted. The analysis implied that statistical power (power = 0.96) was sufficient, rendering it unlikely that significant differences between the groups could have been overlooked.

Results
=======

Of the 391 participants, 59.3% of reported experiencing CTA. CTA was reported more in females than males (χ^2^ = 19.7, *df* = 1, *p* \< 0.001). **Table [1](#T1){ref-type="table"}** depicts the results of the univariate analyses comparing CTA and no CTA participants on socio-demographic data. Participants who had experienced CTA were more likely to be married or living in a *de facto* relationship (χ^2^ = 13.2, *df* = 2, *p* = 0.001), and had left school earlier (*t* = --3.22, *df* = 389, *p* = 0.001). There was no difference in diagnosis or in rates of current smoking, lifetime history of heavy alcohol use, or cannabis use, between those with and without CTA.

###### 

Socio-demographic data for people with psychosis, comparing those who had experienced childhood trauma and/or adversity (CTA) with those who had not.

                                           CTA (*n* = 232)   No CTA (*n* = 159)   Total (*n* = 391)   *p*                  
  ---------------------------------------- ----------------- -------------------- ------------------- ------ ------ ------ ---------
  **Age and sex**                                                                                                          
  Female (*n*, %)                          118               50.9                 45                  28.3   163    41.7   \<0.001
  Age (mean ± SD, years)                   39.1              10.2                 37.5                11.1   38.4   10.5   0.16
  Age left school (mean ± SD, years)       15.8              1.3                  16.3                1.2    16.0   1.3    0.001
  **Marital status (*n*, %)**                                                                                              
  Single                                   106               45.7                 102                 84.6   208    53.2   0.001
  Married/*de facto*                       59                25.4                 24                  15.1   83     21.2   
  Currently separated, divorced, widowed   67                28.9                 33                  20.8   100    25.5   
  **Income (*n*, %)**                                                                                                      
  Main income source: pension              212               91.8                 147                 93.0   359    92.3   0.65
  Duration of illness (years)              15.3              10.0                 13.2                9.4    14.4   9.8    0.043
  **Employment (*n*, %)**                                                                                                  
  Paid Employment (past year)              54                23.3                 38                  23.9   92     23.5   0.89
  Voluntary/Unpaid work (past 12 months)   0.34              14.7                 20                  12.6   54     13.8   0.56

Physical and Psychological Health
---------------------------------

**Table [2](#T2){ref-type="table"}** displays the results for the univariate analyses on physical health. The CTA group generally indicated higher rates of reported lifetime physical health conditions. More of the CTA positive group experienced chronic pain (χ^2^ = 18.24, *df* = 1, *p* = 0.001), headaches/migraines (χ^2^ = 19.73, *df* = 1, *p* = 0.001), arthritis (χ^2^ = 10.88, *df* = 1, *p* = 0.001) and asthma (χ^2^ = 5.52, *df* = 1, *p* = 0.019). In the overall sample, cardiovascular disease and/or stroke was also more common in the CTA positive group (χ^2^ = 9.80, *df* = 1, *p* = 0.002).

###### 

Lifetime physical conditions.

                                              CTA (*n* = 232)   No CTA (*n* = 159)   Total (*n* = 391)   *p*                 
  ------------------------------------------- ----------------- -------------------- ------------------- ------ ----- ------ ---------
  **Lifetime physical conditions (*n*, %)**                                                                                  
  Chronic pain                                101               43.5                 35                  22.4   136   35.1   \<0.001
  Asthma                                      81                34.9                 37                  23.7   118   30.4   0.019
  Cardiovascular/stroke                       54                23.5                 17                  10.9   71    18.4   0.002
  Severe headaches/migraines                  89                38.4                 27                  17.3   116   29.9   \<0.001
  Arthritis                                   64                27.6                 21                  13.5   85    21.9   0.001
  Diabetes                                    56                24.5                 39                  25.2   95    24.7   0.88
  Epilepsy                                    25                10.8                 10                  6.5    35    9.0    0.15
  Cancer                                      11                4.7                  4                   2.6    15    3.9    0.28
  **Males (*n*, %)**                                                                                                         
  Chronic pain                                41                36.0                 25                  22.1   66    29.1   0.022
  Asthma                                      33                29.0                 24                  21.2   57    25.1   0.18
  Cardiovascular/stroke                       27                23.7                 11                  9.7    38    16.7   0.005
  Severe headaches/migraines                  39                34.2                 18                  15.9   57    25.1   0.001
  Arthritis                                   20                17.5                 9                   8.0    29    12.8   0.031
  Diabetes                                    26                23.2                 24                  21.4   50    22.3   0.75
  Epilepsy                                    18                15.8                 7                   6.2    25    11.0   0.021
  Cancer                                      2                 1.8                  3                   2.7    5     2.2    0.64
  **Females (*n*, %)**                                                                                                       
  Chronic pain                                60                50.9                 10                  23.3   70    43.5   0.002
  Asthma                                      48                40.7                 13                  30.2   61    37.9   0.23
  Cardiovascular/stroke                       27                23.3                 6                   14.0   33    20.8   0.20
  Severe headaches/migraines                  50                42.4                 9                   20.9   59    36.7   0.012
  Arthritis                                   44                37.3                 12                  27.9   56    34.8   0.27
  Diabetes                                    30                25.6                 15                  34.9   45    28.1   0.25
  Epilepsy                                    7                 5.9                  3                   7.1    10    6.3    0.78
  Cancer                                      9                 7.6                  1                   2.3    10    6.2    0.21

More males with a history of CTA than expected reported chronic pain (χ^2^ = 5.2, *df* = 1, *p* = 0.022), cardiovascular disease/stroke (χ^2^ = 7.9, *df* = 1, *p* = 0.005), headaches/migraines (χ^2^ = 10.0, *df* = 1, *p* = 0.001), arthritis (χ^2^ = 4.7, *df* = 1, *p* = 0.031) and epilepsy (χ^2^ = 5.3, *df* = 1, *p* = 0.021). More females with CTA than expected reported chronic pain (χ^2^ = 9.8, *df* = 1, *p* = 0.002) and headaches/migraines (χ^2^ = 6.2, *df* = 1, *p* = 0.012).

Univariate analyses revealed that the CTA positive group experienced different rates of lifetime psychological symptoms than the non-CTA group (**Table [3](#T3){ref-type="table"}**). For example, the CTA group were more likely to report a lifetime history of depressive mood (χ^2^ = 7.96, *df* = 1, *p* = 0.005), anhedonia (χ^2^ = 14.30, *df* = 1, *p* = 0.001), poor concentration (χ^2^ = 4.67, *df* = 1, *p* = 0.031), elevated mood (χ^2^ = 5.16, *df* = 1, *p* = 0.023). However, the non-CTA group were more likely to report a lack of insight (χ^2^ = 5.68, *df* = 1, *p* = 0.017). Males with CTA also were more likely to have experienced anhedonia (χ^2^ = 8.44, *df* = 1, *p* = 0.004) and subjective thought disorder (χ^2^ = 3.87, *df* = 1, *p* = 0.049). Conversely, females with CTA were more likely to have reported depressive mood symptoms (χ^2^ = 5.59, *df* = 1, *p* = 0.018) and elevated mood symptoms (χ^2^ = 4.30, *df* = 1, *p* = 0.038).

###### 

Psychological symptoms: lifetime.

                                   CTA (*n* = 232)   No CTA (*n* = 159)   Total (*n* = 391)   *p*                 
  -------------------------------- ----------------- -------------------- ------------------- ------ ----- ------ ---------
  **Lifetime symptoms (*n*, %)**                                                                                  
  Delusions                        213               91.8                 148                 93.1   361   92.3   0.64
  Hallucinations                   194               83.6                 135                 84.9   329   84.1   0.73
  Subjective thought disorder      159               68.5                 94                  59.1   253   64.7   0.06
  Depressed mood                   212               91.4                 130                 81.8   342   87.5   0.005
  Anhedonia                        203               87.5                 115                 72.3   318   81.3   \<0.001
  Suicidal ideation                171               73.7                 105                 66.0   276   70.6   0.10
  Poor concentration               179               77.2                 107                 67.3   286   73.2   0.031
  Irritable Mood                   87                37.5                 55                  34.6   142   36.3   0.56
  Elevated Mood                    110               47.4                 57                  35.9   167   42.7   0.023
  Lack of insight                  47                20.3                 49                  30.8   96    24.6   0.017
  **Males (*n*, %)**                                                                                              
  Delusions                        105               92.1                 105                 92.1   210   92.1   1.00
  Hallucinations                   95                83.3                 99                  86.8   194   85.1   0.46
  Subjective thought disorder      83                72.8                 69                  60.5   152   66.7   0.049
  Depressed mood                   98                86.0                 91                  79.8   189   82.9   0.22
  Anhedonia                        95                83.3                 76                  66.7   171   75.0   0.004
  Suicidal ideation                84                73.7                 76                  66.7   160   70.2   0.25
  Poor concentration               77                67.5                 73                  64.0   150   65.8   0.58
  Irritable mood                   35                30.7                 36                  31.6   71    31.1   0.89
  Elevated mood                    44                38.6                 40                  35.1   84    36.8   0.58
  Lack of insight                  26                22.8                 38                  33.3   64    28.1   0.08
  **Females (*n*, %)**                                                                                            
  Delusions                        108               91.5                 43                  95.6   151   92.6   0.38
  Hallucinations                   99                83.9                 36                  80.0   135   82.8   0.56
  Subjective thought disorder      76                64.4                 25                  55.6   101   62.0   0.30
  Depressed mood                   114               96.6                 39                  86.7   153   93.9   0.018
  Anhedonia                        108               91.5                 39                  86.7   147   90.2   0.35
  Suicidal ideation                87                73.7                 29                  64.4   116   71.2   0.24
  Poor concentration               102               86.4                 34                  75.6   136   83.4   0.10
  Irritable mood                   52                44.1                 19                  42.2   71    43.6   0.83
  Elevated mood                    66                55.9                 17                  37.8   83    50.9   0.038
  Lack of insight                  21                17.8                 11                  24.4   32    19.6   0.34

Physical and Psychological Health Profile
-----------------------------------------

**Table [4](#T4){ref-type="table"}** displays the results of the final multivariate logistic regression model for men and women, adjusted for age at interview and socioeconomic status. Most of the physical and psychological health variables that had been significant in the univariate analyses were no longer so in the multivariate models for either gender. However, males who had experienced CTA were more likely to report experiencing a lifetime history of cardiovascular/stroke health issues, migraines and anhedonia. Conversely, females who had experienced CTA were significantly more likely to be in a married/*de facto* relationship and a lifetime history of elevated mood. The physical health measures were not significantly associated with CTA.

###### 

Relationship between CTA and demographics, psychological and physical health profiles in people with psychosis, stratified by sex.

                                           Males                         Females                               
  ---------------------------------------- ----------------- ----------- ----------------- ------ ------------ ------
  Age at interview                         0.98              0.9--1.0    0.36              1.04   0.9--1.1     0.29
  Marital status                                                                                               
  Single, never married                    Reference group               Reference group                       
  Married/*de facto*                       --                                              4.89   1.2--19.2    0.02
  Currently separated, divorced, widowed   --                                              2.05   0.6--7.5     0.28
  Lifetime history of smoking              0.41              0.1--2.6    0.34              1.24   0.6--27.3    0.89
  Lifetime history of heavy alcohol use    1.43              0.7--3.0    0.34              1.39   0.4--4.4     0.57
  Lifetime history of cannabis use         0.93              0.9--1.0    0.07              1.07   0.9--1.2     0.18
  Psychological symptoms                                                                                       
  Anhedonia                                2.70              1.2--5.9    0.012             --                  
  Elevated Mood                            --                                              4.11   1.38--12.2   0.01
  Physical symptoms                                                                                            
  Cardiovascular/Stroke                    4.18              1.5--11.8   0.007             --                  
  Migraines                                3.08              1.2--7.1    0.008             --                  

Discussion
==========

Considerable research has been conducted into the effect of CTA on health, psychological, and social functioning in female populations. Associations between CTA and physical illnesses, including cardiac, respiratory, and gastrointestinal diseases, has also been reported in general population samples ([@B13]). However, CTA in male cohorts has received less consideration, primarily due to its seemingly lower prevalence rates and less overt symptomatic presentation(s). The high rate of the self-reporting of physical illness in male psychosis populations such as ours may be evidence of a CTA history. Most significantly, it may characterize a psychological disorder, one that represents a manifestation of an undisclosed CTA experience(s). Self-reported health risks can potentially compound the already high health, psychological, and social burden associated with psychotic illness for this population. These represent deficits that can exacerbate the psychological burden of the experience(s) of CTA. The SHIP cohort presented with a myriad of physical, psychological, and social challenges that did not translate into multivariate explanatory models. Given that the entire sample was in poor physical and psychological health and were socio-economically marginalized, this should not surprise. Overall, prevalence of CTA was high, with over 60% of participants reporting physical, sexual and/or emotional abuse, and neglect. This is consistent with the association between CTA and adult psychotic disorders ([@B23]; [@B21]). Participants with a CTA history left school earlier and experienced higher rates of employment. Conversely, unlike general population samples where CTA has been associated with higher rates of substance use ([@B10]), the CTA cohort in this sample did not replicate this research. Furthermore, the CTA cohort was more likely to be married and have children, suggesting a better capacity to form intimate relationships. Additionally, the self-reported poorer physical health, which was more prominent in men, may reflect somatic expression of emotional distress, or poorer self-care with greater vulnerability to physical illness.

Our study accessed a large representative sample of people with psychotic illness living in a disadvantaged region of urban Adelaide, South Australia. The finding that CTA may influence and potentially compromise health functioning among adults with psychosis is intriguing. Despite this, there has been very little research into the assessment and treatment of the effects of CTA in adults with psychosis. Thus, there are unanswered questions about the role of CTA in the symptoms and outcomes of men with psychosis and this awaits future research. Further research is also needed to determine the extent to which the relationship between CTA and health and psychosocial functioning is moderated by other intervening variables, such as cognitive function, substance abuse, and illness symptomology, in psychosis populations. A significant portion of non-psychosis trauma in the literature links CTA to deficits in areas such as psychological and social functioning ([@B26]) as well as health functioning ([@B27]). Nonetheless, our sample unexpectedly did not replicate this association, either at a univariate or multivariate level of analysis. Our findings suggest that interventions are urgently needed. These challenges highlight the importance of an integrated approach to mental health and community based service provision. Such an approach may help to ensure that people with psychosis and the experience(s) of CTA have their health and social needs met in ways that can enhance their illness recovery. Answers to these questions will help in better understanding the processes surrounding health and psychosocial functioning in psychosis populations and to develop and deliver more effective clinical treatments. The population-level data collected as part of the 2010 SHIP research provide a solid empirical foundation to guide health and social policy development and the provision of mental health services regarding many aspects of psychosis/CTA populations.

Limitations
-----------

This study has a number of important limitations. Although we were able to explore the temporal relationship between self-reported physical health and clinical outcomes in adulthood, we were unable to determine severity, frequency, duration and perpetrator of the abuse due to the interview design. Therefore, we may have missed important patterns of association. In addition, we acknowledge that longitudinal studies that collect CTA data prospectively are the optimal design for this type of research.

As our data rely on retrospective self-report, the accuracy may be affected by recall bias. However, a number of studies have demonstrated the validity and reliability of retrospective reports of trauma in psychosis populations. These studies indicated that reports of CTA are stable across time, unaffected by current symptoms, and generally correlate well with other sources of information ([@B3]). Additionally, there is evidence that the retrospective assessment of child abuse tends to underestimate rather than over-report real rates, possibly due to poor memory, denial, or embarrassment. Consequently, our data may underestimate the strength of the relationship between CTA and subsequent outcomes.
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